Research location
Temecula
California, United States
Advertisement
Research activity in Temecula
California, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 120 trials and 120 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Temecula
120 linked trials · page 1 of 3Phase 1a/b Tolerability of NTR-1011 in Healthy Adults and Adult Patients With SLE and RANCT07237659 · 2026-07-15 · 1 site observation
RECRUITING
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive DisorderNCT07276997 · 2025-12-18 · 1 site observation
RECRUITING
Study of ALTO-300 in MDDNCT05922878 · 2023-06-08 · 1 site observation
RECRUITING
A Study to Evaluate Sleep Electroencephalogram (EEG) Features (Brain Activity While Sleeping) in Participants With Major Depressive Disorder (MDD)NCT07258485 · 2025-11-24 · 1 site observation
COMPLETED
At-home Ultrasound Localized Therapy for Rheumatoid Arthritis Study [At-home ULTRA Study]NCT07163221 · 2025-11-03 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)NCT06864026 · 2025-03-06 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Evaluate the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat Rheumatoid ArthritisNCT06754462 · 2025-01-10 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive DisorderNCT06785012 · 2024-12-26 · 1 site observation
COMPLETED
Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or OverweightNCT06588296 · 2024-09-24 · 1 site observation
COMPLETED
A Study of Aticaprant 10 mg as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy and Long-term Extension Treatment With AticaprantNCT06514742 · 2024-06-26 · 1 site observation
TERMINATED
Open-Label of SPN-820 in Adults With Major Depressive DisorderNCT06235905 · 2024-02-15 · 1 site observation
COMPLETED
Study to Assess the Safety and Effectiveness of NMRA-335140-501NCT06029439 · 2023-11-10 · 1 site observation
TERMINATED
Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive DisorderNCT06029426 · 2023-09-20 · 1 site observation
COMPLETED
A Study of Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis (RENOIR)NCT06041269 · 2023-08-31 · 1 site observation
ACTIVE_NOT_RECRUITING
Study to Evaluate TNX-601 ER Monotherapy Versus Placebo in Patients With Major Depressive Disorder (MDD)NCT05686408 · 2023-03-02 · 1 site observation
COMPLETED
Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide AcetateNCT05605964 · 2023-01-28 · 1 site observation
COMPLETED
A Trial of the Safety and Efficacy of SEP-363856 in the Treatment of Adults With Major Depressive DisorderNCT05593029 · 2022-11-09 · 1 site observation
COMPLETED
A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD)NCT05518149 · 2022-09-22 · 1 site observation
TERMINATED
Trial of Centanafadine Efficacy and Safety as Monotherapy or as Adjunct to SSRI in Adults With Major Depressive DisorderNCT05536414 · 2022-09-12 · 1 site observation
COMPLETED
A Study of Aticaprant as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant TherapyNCT05455684 · 2022-06-22 · 1 site observation
COMPLETED
A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's DiseaseNCT05310071 · 2022-06-02 · 1 site observation
TERMINATED
Efficacy and Safety of Depemokimab (GSK3511294) in Participants With Chronic Rhinosinusitis With Nasal PolypsNCT05274750 · 2022-04-22 · 1 site observation
COMPLETED
An Open-label Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive DisorderNCT05061719 · 2021-10-08 · 1 site observation
COMPLETED
Clinical Trial of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive DisorderNCT04985942 · 2021-07-30 · 1 site observation
COMPLETED
A Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Alzheimer's Disease AgitationNCT04947553 · 2021-06-17 · 1 site observation
COMPLETED
A Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major Depressive Disorder (MDD)NCT04855747 · 2021-03-30 · 1 site observation
TERMINATED
Assessing Clinical Outcomes in Alzheimer's Disease AgitationNCT04797715 · 2020-12-31 · 1 site observation
COMPLETED
A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With DepressionNCT04521478 · 2020-11-20 · 1 site observation
COMPLETED
A Comparative Study of Sage-217 Plus an Antidepressant (ADT) Versus Placebo Plus an ADT in Adults With Major Depressive DisorderNCT04476030 · 2020-11-09 · 1 site observation
COMPLETED
A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant and Long-term Safety Extension Treatment With SeltorexantNCT04533529 · 2020-09-16 · 1 site observation
COMPLETED
A Study to Evaluate the Efficacy of Sage-217 in the Treatment of Adult Participants With Major Depressive Disorder (MDD)NCT04442490 · 2020-05-12 · 1 site observation
COMPLETED
Comparison of SAR341402 to NovoLog in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin GlargineNCT03874715 · 2019-03-11 · 1 site observation
COMPLETED
A Study to Evaluate SAGE-217 in Adult Participants With Major Depressive Disorder (MDD)NCT03864614 · 2019-02-27 · 1 site observation
COMPLETED
A Study to Evaluate the Safety, Tolerability, and Efficacy of SAGE-217 Compared to Placebo in Adult Participants With Comorbid Major Depressive Disorder (MDD) and InsomniaNCT03771664 · 2019-02-04 · 1 site observation
TERMINATED
A Study to Evaluate the Efficacy of SAGE-217 in the Treatment of Adult Participants With Major Depressive DisorderNCT03672175 · 2018-11-19 · 1 site observation
COMPLETED
Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants AloneNCT03738215 · 2018-11-09 · 1 site observation
COMPLETED
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)NCT03620357 · 2018-09-05 · 1 site observation
COMPLETED
Study of Adjunctive or Monotherapy Rapastinel Treatment in Patients With Major Depressive Disorder (MDD)NCT03668600 · 2018-08-23 · 1 site observation
TERMINATED
A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD)NCT03610048 · 2018-08-09 · 1 site observation
TERMINATED
Study of Monotherapy Rapastinel in the Prevention of Relapse in Patients With Major Depressive Disorder (MDD)NCT03614156 · 2018-08-02 · 1 site observation
TERMINATED
Study of Rapastinel as Monotherapy in Patients With MDDNCT03560518 · 2018-06-15 · 1 site observation
TERMINATED
AV-101 as Adjunct Antidepressant Therapy in Patients With Major DepressionNCT03078322 · 2018-03-05 · 1 site observation
COMPLETED
Efficacy and Safety of Soliqua Versus Lantus in Ethnically/Racially Diverse Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic AgentsNCT03434119 · 2018-02-20 · 1 site observation
TERMINATED
Proof-of-Concept Study of a Selective p38 MAPK Alpha Inhibitor, Neflamapimod, in Subjects With Mild Alzheimer's DiseaseNCT03402659 · 2017-12-29 · 1 site observation
COMPLETED
Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular RiskNCT03315143 · 2017-12-19 · 1 site observation
TERMINATED
Real-life Effectiveness of Vortioxetine in DepressionNCT03555136 · 2017-11-17 · 1 site observation
COMPLETED
Addressing Dementia Via Agitation-Centered EvaluationNCT03226522 · 2017-07-13 · 1 site observation
COMPLETED
Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831NCT03201757 · 2017-06-15 · 1 site observation
COMPLETED
A Study of ALKS 5461 for Treatment Refractory Major Depressive Disorder (MDD)NCT03188185 · 2017-06-12 · 1 site observation
COMPLETED
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive DisorderNCT03002077 · 2017-02-03 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.